Health & Fit Coronavirus. Vaccine for Latin America scheduled for Q1 2021

09:25  14 august  2020
09:25  14 august  2020 Source:   ouest-france.fr

Emboldened Anti-Vaccine Movement Threatens The Return To Normality

  Emboldened Anti-Vaccine Movement Threatens The Return To Normality Scientists hoped the battle against the coronavirus would be won in the laboratory. According to the latest updates, a vaccine could be ready to roll out to the public in a matter of months. “We anticipate if everything goes really well that we’ll get an answer as to whether it works by early next year,” professor Robin Shattock, who heads a team developing a coronavirus vaccine at Imperial College London, said this week, per HuffPost U.K. Already, approximately 15 volunteers have been vaccinated as part of the trial, and an additional 200 to 300 participants will be added in the coming weeks, Shattock said.

A total of 20 nations from Latin America , the Middle East, and Asia have already requested doses of Russia’s breakthrough coronavirus vaccine , which At a conference dedicated to the announcement of the vaccine ’s registration, the CEO of the Russian Direct Investment Fund (RDIF) explained that it

A vaccine would normally take years, if not decades, to develop. Researchers hope to achieve the same amount of work in only a few months. Four coronaviruses already circulate in human beings. They cause common cold symptoms and we don't have vaccines for any of them.

L’Argentine et le Mexique vont prendre en charge la production et la distribution en Amérique latine du futur vaccin contre le coronavirus. (Photo d'illustration) © SIPHIWE SIBEKO / AFP Argentina and Mexico will support the production and distribution in Latin America of the future vaccine against the coronavirus. (Illustrative photo)

Manufacturing of the future coronavirus vaccine for Latin America could start at the end of the year "to have the vaccine available from the first quarter of next year." It should be "universal and free" in Mexico.

The vaccine against Covid-19 on which the Anglo-Swedish laboratory AstraZeneca is working and which must be produced in Argentina and Mexico for Latin American countries (except Brazil) should be ready in the first quarter of 2021, Mexican President Andrés Manuel López Obrador assured Thursday.

Doctors Break Down the Long Road Ahead to Getting a Viable COVID-19 Vaccine

  Doctors Break Down the Long Road Ahead to Getting a Viable COVID-19 Vaccine Adrian Hill, the lead researcher in Oxford University's vaccine test on humans, shares encouraging results from their testing, and says they are still hoping to have a Covid-19 vaccine by the end of the year.

A COVID‑19 vaccine is a biotechnology intended to provide acquired immunity against coronavirus disease 2019 (COVID‑19). In July 2020, 218 vaccine candidates were in development, although no candidate has completed clinical trials to prove its safety and efficacy.

Latin America . Russian President Vladimir Putin has said a locally developed vaccine for Covid-19 has been given regulatory approval after less than two months of testing on humans. The progress Russia says it has made on a coronavirus vaccine has been met with scepticism by health officials

"We are shortening the process […], but we think we will have results by the end of November […] and start manufacturing in order to have the vaccine available from the first quarter of next year" , said the manager at a conference of hurry.

Argentina and Mexico will take charge of the production and distribution in Latin America of the future vaccine against the coronavirus jointly developed by the laboratory AstraZeneca and the University of Oxford, with funding from the Carlos Slim Foundation. Brazil is not affected because it has made a separate agreement.

"Universal and free"

President Lopez Obrador assured that the vaccine would be "universal and free" in Mexico. “All Mexicans will have access to the vaccine. The most humble don't have to worry, ", said the leftist head of state. "The idea is not to make a profit, but to guarantee access to Latin America" ​​, Mexican foreign minister Marcelo Ebrard said at the same press conference.

Mr. Ebrard will chair a virtual meeting of the Community of Latin American and Caribbean States (CELAC) to present this agreement on the vaccine and its distribution in the region, the organization said on Twitter.

Here are the most promising coronavirus vaccine candidates out there .
Scientists around the world are creating dozens of unique vaccine candidates to fight the novel coronavirus — and they're doing it at unprecedented speeds. require(["medianetNativeAdOnArticle"], function (medianetNativeAdOnArticle) { medianetNativeAdOnArticle.getMedianetNativeAds(true); }); Over seven months after the World Health Organization (WHO) first alerted the world to a mysterious cluster of pneumonia cases in Wuhan, China, 167 candidate vaccines are in development to prevent the coronavirus that caused the disease (called COVID-19), according to WHO.

—   Share news in the SOC. Networks
usr: 0
This is interesting!